Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Xenon Pharmaceuticals Inc. (Nasdaq:XENE) announced its participation in two upcoming virtual investor conferences. The first is the 20th Annual Needham Virtual Healthcare Conference on April 15, 2021, at 10:15 am ET, accessible via a live webcast. The second is the 2021 Bloom Burton & Co. Healthcare Investor Conference on April 20, 2021, at 3:00 pm ET, also available through a live webcast. The company focuses on developing innovative therapeutics for neurological disorders, particularly epilepsy. More information can be found on their investor website.
- None.
- None.
BURNABY, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage biopharmaceutical company, today announced that members of its executive management team will present a corporate overview and participate in the following virtual investor conferences:
- 20th Annual Needham Virtual Healthcare Conference on Thursday, April 15, 2021 at 10:15 am ET. The live webcast of the fireside chat can be accessed here.
- 2021 Bloom Burton & Co. Healthcare Investor Conference on Tuesday, April 20, 2021 at 3:00 pm ET. The live webcast of the company presentation can be accessed here.
Details on company presentations and the links to webcasts can be found on the “Investors” section of Xenon’s website at http://investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event for 30 days. The above listed dates and times are subject to change.
About Xenon Pharmaceuticals Inc.
We are a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.
“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.
Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com
FAQ
What conferences is Xenon Pharmaceuticals participating in April 2021?
What is the date and time for the Needham Virtual Healthcare Conference?
When will the Bloom Burton & Co. Healthcare Investor Conference occur?
Where can I watch the webcasts for Xenon Pharmaceuticals' presentations?